LBF232nnPG03: Difference between revisions
No edit summary |
No edit summary |
||
(15 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1794 | |LipidBank=XPR1794 | ||
|LipidMaps=LMFA03010123 | |LipidMaps=LMFA03010123 | ||
|SysName= | |SysName=(9alpha,11alpha,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (cis-5,trans-13) -dien-1-amide | ||
|Common Name=&&17-phenyl trinor Prostaglandin | |Common Name=&&17-phenyl trinor Prostaglandin F_2 alpha amide&&(9alpha,11alpha,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (5Z,13E) -dien-1-amide&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=17-phenyl trinor PGF2 alpha amide is expected to show the typical intraocular effects of latanoprost. In vivo study revlealed that 17-phenyl trinor PGF2 alpha amide was converted the amides of various PGs to the free acids.[[Reference:Woodward_DF:Krauss_AH:Chen_J:Lai_RK:Spada_CS:Burk_RM:Andrews_SW:Shi_L:Liang_Y:Kedzie_KM_et_al:,Surv. Ophthalmol.,2001,45 Suppl 4,S337|{{RelationTable/GetFirstAuthor|Reference:Woodward_DF:Krauss_AH:Chen_J:Lai_RK:Spada_CS:Burk_RM:Andrews_SW:Shi_L:Liang_Y:Kedzie_KM_et_al:,Surv. Ophthalmol.,2001,45 Suppl 4,S337}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 18:06, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1794 |
LipidMaps | LMFA03010123 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF232nnPG03 |
17-phenyl trinor Prostaglandin F2α amide | |
---|---|
Structural Information | |
(9α,11α,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (cis-5,trans-13) -dien-1-amide | |
| |
Formula | C23H33NO4 |
Exact Mass | 387.24095854899997 |
Average Mass | 387.51246 |
SMILES | C(c(c2)cccc2)C[C@@H](C=C[C@H]([C@H]1CC=CCCCC(N)=O)[C@@H](C[C@H](O)1)O)O |
Physicochemical Information | |
17-phenyl trinor PGF2 alpha amide is expected to show the typical intraocular effects of latanoprost. In vivo study revlealed that 17-phenyl trinor PGF2 alpha amide was converted the amides of various PGs to the free acids. Woodward_DF et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|